To evaluate the ability of TDP‐43_SAA to detect TDP‐43 proteinopathies, we compared 30 patients with GRN and C9orf72 mutations with the other 29 subjects of the cohort (including the 27 CTRLs and the 2 patients with MAPT mutations). This evidence concerns the gene C9orf72 and proteostasis deficiencies.